Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer

about

Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer

Item

http://www.wikidata.org/entity/Q57298068

description

scientific article published on 03 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Prognostic significance of p16 ...... triple negative breast cancer

@en

Prognostic significance of p16 ...... triple negative breast cancer

@nl

type

Item

label

Prognostic significance of p16 ...... triple negative breast cancer

@en

Prognostic significance of p16 ...... triple negative breast cancer

@nl

prefLabel

Prognostic significance of p16 ...... triple negative breast cancer

@en

Prognostic significance of p16 ...... triple negative breast cancer

@nl

P1476

Prognostic significance of p16 ...... triple negative breast cancer

@en

P2093

Atif Ali Hashmi

http://www.w3.org/2001/XMLSchema#string

Erum Yousuf Khan

http://www.w3.org/2001/XMLSchema#string

Muhammad Irfan

http://www.w3.org/2001/XMLSchema#string

Naveen Faridi

http://www.w3.org/2001/XMLSchema#string

Samreen Naz

http://www.w3.org/2001/XMLSchema#string

Shumaila Kanwal Hashmi

http://www.w3.org/2001/XMLSchema#string

Zubaida Fida Hussain

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Gene expression patterns associated with p53 status in breast cancer.

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.

P16 and p53 play distinct roles in different subtypes of breast cancer

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

P2888

s12907-018-0077-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12907-018-0077-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Muhammad Muzzammil Edhi

Amir Khan

P577

2018-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107381394

http://www.w3.org/2001/XMLSchema#string

P698

30305801

http://www.w3.org/2001/XMLSchema#string

P921

Cho͘-chit-ha̍k

immunohistochemistry

P932

6171321

http://www.w3.org/2001/XMLSchema#string